Ezetimibe Plus Statin: Attractive Bypass to High-Dose Monotherapy

Early initiation of this approach should be considered in patients with challenging lipid disorders who are at increased risk of atherosclerotic cardiovascular disease events, observers say.
Medscape Medical News